These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6609257)

  • 1. [The relationship between serum immune complex levels and peripheral lymphocyte subpopulations in systemic lupus erythematosis].
    Kiso N
    Nihon Jinzo Gakkai Shi; 1983 Oct; 25(10):1183-8. PubMed ID: 6609257
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmapheresis in systemic lupus erythematosus: effects on cellular immunity.
    Vangelista A; Frascà GM; Nanni-Costa A; Bonomini V
    Trans Am Soc Artif Intern Organs; 1983; 29():749-53. PubMed ID: 6608818
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serial changes of lymphocyte subpopulations, anti-T cell antibodies, and circulating immune complexes in patients with lupus nephritis, nephrotic syndrome and poststreptococcal acute glomerulonephritis (author's transl)].
    Nakabayashi K; Yoshida M; Nagasawa T
    Nihon Jinzo Gakkai Shi; 1981 Mar; 23(3):253-63. PubMed ID: 6975844
    [No Abstract]   [Full Text] [Related]  

  • 4. [Increased immune reactivity in systemic lupus erythematosus. III. Different in vitro stimulation of lymphocytic populations by mitogenic serum factors (author's transl)].
    Günther W; Diezel W; Meffert H; Sönnichsen N
    Dermatol Monatsschr; 1978 Oct; 164(10):711-4. PubMed ID: 310779
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced Fc-receptor bearing cells in peripheral bloods of patients with systemic lupus erythematosus and in rheumatoid synovial fluids.
    Nakai H; Morito T; Tanimoto K; Horiuchi Y
    J Rheumatol; 1977; 4(4):405-13. PubMed ID: 415139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous rosette formation in systemic lupus erythematosus.
    Bodolay E; Szegedi G
    Acta Med Hung; 1983; 40(2-3):81-9. PubMed ID: 6608094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of C3 rosette formation by serum from patients with systemic lupus erythematosus. A corollary of disease activity.
    Scheinberg MA; Israel Filho G; Mendes NF; Vertzman L
    J Rheumatol; 1978; 5(1):19-25. PubMed ID: 305960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical application of Fc-rosette. 1. Inhibition of Fc-rosette formation by systemic lupus erythematosus sera. A method for detection of circulating immune complexes].
    Moyito T; Aotsuka S; Yokohari R; Moroi Y; Yokohari R
    Ryumachi; 1976 Mar; 16(1):4-11. PubMed ID: 1085992
    [No Abstract]   [Full Text] [Related]  

  • 9. [Relationship between the serum immune complex levels and the peripheral lymphocyte subpopulations in chronic glomerulonephritis].
    Kiso N
    Nihon Jinzo Gakkai Shi; 1983 Nov; 25(11):1317-24. PubMed ID: 6609258
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of T-cells and B-cells in SLE and RA].
    Nakai H; Nakamura T; Tanimoto K
    Nihon Rinsho; 1978 Dec; 36(12):3945-50. PubMed ID: 311861
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibitory effect of sera from patients with rheumatic diseases on EA-rosette formation].
    Nasonov EL; Aleksandrova EN; Sura VV; Ivanova MM; Zimin IuI
    Ter Arkh; 1983; 55(7):32-7. PubMed ID: 6604958
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic studies on systemic lupus erythematosus.
    Shi SY; Kang KF; Weng MW; Tian RM; Hou AQ
    Chin Med J (Engl); 1985 May; 98(5):336-42. PubMed ID: 3926405
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum complements and circulating immune complex in patients with systemic lupus erythematosus].
    Tang HY
    Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):83-6. PubMed ID: 6407735
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunity in systemic lupus erythematosus].
    Ofuji T
    Nihon Rinsho; 1984 May; 42(5):1147-53. PubMed ID: 6332215
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immune rosette inhibiting activity of serum from patients with chronic lupus erythematosus treated with chloroquin].
    Nagy E; Szegedi G; Tamási P; Sonkoly I
    Dermatol Monatsschr; 1978 Jun; 164(6):408-10. PubMed ID: 308469
    [No Abstract]   [Full Text] [Related]  

  • 16. [Autoantibodies in systemic erythematosis. I. Incidence of antibodies against the CEM T-lymphocyte line].
    Jíra M; Strejcek J; Antosová E; Rejholec V; Singerová D; Zavadil Z
    Vnitr Lek; 1988 Nov; 34(11):1062-8. PubMed ID: 3264641
    [No Abstract]   [Full Text] [Related]  

  • 17. [Surface markers of peripheral blood T- and B-lymphocytes in patients with rheumatoid diseases].
    Stankaitene DI; Redaitene EI; Rulis AK; Ianulevichiute NA
    Ter Arkh; 1981; 53(7):6-11. PubMed ID: 7027511
    [No Abstract]   [Full Text] [Related]  

  • 18. Scientific overview of systemic lupus erythematosus (SLE).
    Jasin HE
    Prog Clin Biol Res; 1982; 106():65-80. PubMed ID: 6757954
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interrelationships of cellular and humoral immunity indices in systemic lupus erythematosus].
    Matveĭkov GP; Dosin IuM; Kaliia ES; Koshelev VK; Nazarov IuM
    Ter Arkh; 1982; 54(12):44-8. PubMed ID: 6984235
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison studies on levels of CIC, complement C and its breakdown product C3c in chronic bronchitis and systemic lupus erythematosis].
    Hou JC; Yu W; Kou MX; Ling YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):232-3. PubMed ID: 6241058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.